Microgestin 1/20 Kit
Product Images NDC 75907-084

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Microgestin 1/20 (NDC 75907-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Microgestin_1-20 (Microgestin 1 20 1)

Packaging label for Microgestin 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP) kit. The label shows the drug name, active ingredients, dosage form, usual dosage instructions, storage conditions, and manufacturer Dr. Reddy's Laboratories Inc. It indicates the kit contains 6 blister cards of 21 tablets each, with NDC 75907-084-63, and includes barcodes and lot/expiration placeholders.*

FDA Label Image

1 (Image 01)

Chemical structure diagrams of Norethindrone Acetate and Ethinyl Estradiol, the active ingredients in Microgestin 1/20. The structures display detailed molecular formations characteristic of these hormone components used in the kit.*

FDA Label Image

Table Ii (Image 03)

A bar chart titled 'Table II Circulatory Disease Mortality Rates Per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It compares mortality rates among ever-users and controls of oral contraceptives divided by smoking status across four age groups (15-24, 25-34, 35-44, 45+). Mortality rates increase with age, particularly for smokers who are ever-users aged 45 and older.*

FDA Label Image

Table Iii (Image 04)

Table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group (15-44 years). Methods include no fertility control, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates varying by age and method.*

FDA Label Image

Figure 1 (Image 05)

A forest plot chart titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' showing effect estimates (odds ratios, relative risks, hazard ratios) and confidence intervals for various studies comparing breast cancer risk between ever users vs. never users of combined oral contraceptives (COCs), and current COC users vs. never users. The plot presents data points with horizontal lines indicating confidence intervals and a vertical line at effect estimate 1.00.*

FDA Label Image

9 (Image 08)

A table presenting the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. The methods listed include no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with data segmented across six age ranges from 15-19 to 40-44 years.*

FDA Label Image

Image (Image 1)

An instructional diagram for Microgestin 1/20 kit (Norethindrone Acetate/Ethinyl Estradiol) showing how to place a day label sticker on the blister pack and directions to take the pills from left to right each week. It includes guidance for both Sunday starters and Day 1 starters, with arrows pointing to the pill sequence and day label placement instructions.*

FDA Label Image

1 (Picture 1)

FDA Label Image

Table 1 (Table1)

A data table titled 'Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method,' showing percentages of women experiencing unintended pregnancy by contraceptive method. It compares lowest expected and typical failure rates for methods including oral contraceptives, diaphragms, spermicides, vaginal sponges, implants, injections, IUDs, condoms, cervical caps, abstinence, withdrawal, and sterilization.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.